Aimin Li

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Long Noncoding Rna

Top Venues

International journal of nanomedicine

Drug design, development and therapy

Journal of nanobiotechnology

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Na Qi, Xiantai Zhou, Ningzhu Ma, Jianguo Zhang, Zhenlin Wang, Xin Zhang, Aimin Li
Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model. International journal of nanomedicine 19 (2024)
Na Qi, Xiantai Zhou, Ningzhu Ma, Jianguo Zhang, Zhenlin Wang, Xin Zhang, Aimin Li
Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model. International journal of nanomedicine 19 (2024)
Zhenghui Song, Xinhui Liu, Wan Zhang, Yue Luo, Hua Xiao, Yun Liu, Guanqi Dai, Jian Hong, Aimin Li
Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2. Journal of translational medicine 20 (1) (2022)
Yue Luo, Junhao Lin, Jiakang Zhang, Zhenghui Song, Dayong Zheng, Fengsheng Chen, Xuefen Zhuang, Aimin Li, Xinhui Liu
LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma. Canadian journal of gastroenterology & hepatology 2021 (2021)
Na Qi, Shangqian Zhang, Xiantai Zhou, Wenjuan Duan, Duan Gao, Jianfang Feng, Aimin Li
Combined integrin α v β 3 and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect. Journal of nanobiotechnology 19 (1) (2021)
Na Qi, Yu Zhang, Xing Tang, Aimin Li
Cationic/Anionic Polyelectrolyte (PLL/PGA) Coated Vesicular Phospholipid Gels (VPGs) Loaded with Cytarabine for Sustained Release and Anti-glioma Effects. Drug design, development and therapy 14 (2020)